SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000950142-21-001942
Filing Date
2021-06-10
Accepted
2021-06-10 18:47:35
Documents
1
Period of Report
2021-05-24

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT es210157187_4-hurvitz.html 4  
1 OWNERSHIP DOCUMENT es210157187_4-hurvitz.xml 4 10102
  Complete submission text file 0000950142-21-001942.txt   11657
Mailing Address C/O GALMED PHARMACEUTICALS LTD., 8 SHAUL HAMELECH BLVD, AMOT HAMISHPAT BLDG. TEL AVIV L3 64733
Business Address
Hurvitz Chaim (Reporting) CIK: 0001630542 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-38302 | Film No.: 211009423

Mailing Address 1201 N. MARKET STREET SUITE 111 WILMINGTON DE 19801
Business Address 1201 N. MARKET STREET SUITE 111 WILMINGTON DE 19801 484-254-6134
NRX Pharmaceuticals, Inc. (Issuer) CIK: 0001719406 (see all company filings)

IRS No.: 822844431 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations